{"id":"W2307494918","doi":"10.1093/neuonc/now046","title":"Upfront bevacizumab may extend survival for glioblastoma patients who do not receive second-line therapy: an exploratory analysis of AVAglio","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"F. Hoffmann-La Roche; Roche","keywords":"Medicine; Bevacizumab; Internal medicine; Temozolomide; Hazard ratio; Oncology; Proportional hazards model; Post-hoc analysis; Radiation therapy; Progression-free survival; Population; Multivariate analysis; Surgery; Overall survival; Chemotherapy; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003469042,0.0006339206,0.001216349,0.000258631,0.0001775195,0.0008017928,0.0005311696,0.0005845788,0.001249892],"category_scores_gemma":[0.003272327,0.000172319,0.00311769,0.0002199282,0.0002727131,0.0006353375,0.0004380581,0.001171098,0.0001715725],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005970494,"about_ca_system_score_gemma":0.0007954563,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002514976,"about_ca_topic_score_gemma":0.0008820464,"domain_scores_codex":[0.9987349,0.0007683662,0.00005026735,0.0001581392,0.0001377731,0.0001506419],"domain_scores_gemma":[0.9977322,0.001109423,0.0004931847,0.0002153427,0.0001089822,0.0003408075],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.6007083,0.007088367,0.2676033,0.0008499955,0.01129509,0.0007399178,0.0002829957,0.004332143,0.01453022,0.0004991912,0.001907175,0.09016326],"study_design_scores_gemma":[0.06161768,0.3070951,0.5920295,0.0001673185,0.01270178,0.001232142,0.0002535398,0.01037879,0.006737867,0.001605864,0.006095346,0.00008514529],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9976789,0.001187319,0.0002386426,0.0001295655,0.00001899514,0.0001179516,0.0002092803,0.00001002491,0.0004092],"genre_scores_gemma":[0.9982053,0.0002304393,0.0004029315,0.0001218615,0.00005134195,0.0001295525,0.0006132041,0.000006032343,0.0002393661],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003469042,"threshold_uncertainty_score":0.01834625,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03451598792110212,"score_gpt":0.3149871013163817,"score_spread":0.2804711133952796,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}